Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
March 21, 2025 16:30 ET | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE,…
Prime Biome Reviews (Consumer Report Analysis) Safe Ingredients For Skin And Gut Health or Side Effect Complaints?
ST. PETERSBURG, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- The health of…
Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat’s Gut Microbiome Effects from Other Anti-CDI Antibiotics
First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat (IBZ)…
Positive results from the TEZSPIRE Phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps
TEZSPIRE significantly reduced nasal congestion, polyp size and nearly eliminated the need…
LOYALTY PROGRAMS AND THE CURRENCY EFFECT
Global Experts Reveal the Hidden Mechanics of Loyalty Currencies and How Businesses…
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
TAIZHOU, China, Feb. 21, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceutics, Inc.…
adidas and Stars Including Aitana Bonmat, Anthony Edwards and Trinity Rodman Set Out to Make us all Believe, You Got This
adidas’ new brand campaign looks to inspire the world of sport to…
Canoo Inc. Announces 1-for-20 Reverse Stock Split Effective December 24, 2024
December 20, 2024 06:00 ET | Source: Canoo, Inc. JUSTIN, Texas, Dec.…
PureTechs Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial
Dose-ranging trial evaluated deupirfenidone 550 mg three times a day (TID) (approximately…
Azerion announces an update to its Supervisory Board and new additions to its Executive Committee
November 19, 2024 01:35 ET | Source: Azerion Group NV Azerion announces…